Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Performer
432.4000
5.40
(
1.26
%)
NSE
Jun 16, 2026
15:31 PM
61.43% Fall from 52W High
Volume:
317.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
16 Aug 2021, 12:00AM
432.40
1.26%
Suven Pharmaceuticals
Buy:
Cohance Lifesciences Ltd.
by
ICICI Securities Limited
Target: 650
Target
ICICI Securities Limited
Cohance Lifesciences Ltd. is trading
above its 150 day SMA
of 432.2
More from Cohance Lifesciences Ltd.
Recommended
Five stocks to buy from analysts this week - June 16, 2026
The Baseline |
16 Jun 2026, 05:11PM
Market closes higher on easing oil prices and foreign fund inflows
Trendlyne Marketwatch |
16 Jun 2026, 03:55PM
IPO momentum continues with six new issues and three upcoming listings
|
15 Jun 2026, 04:48PM